ProMIS Neurosciences Inc (PMN)

[tex4]

Adding to my last post, look back at post # 60 and read the section on Breakthrough Therapy Designation. It states where breakthrough treatments can receive rapid, priority approval. That is exactly why I think this therapy is very close to approval. There is no way the clinical trials should or will wait until 2019. There are way too many people throughout the world suffering from Alzheimer's and if there is a way to get this drug to market a.s.a.p. , let's hope the red tape gets cut! IMO